(Q37744822)

22 August 2017

Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies (English)

1 reference

22 August 2017

1 reference

1 reference

E C Pietsch

1

1 reference

22 August 2017

J Dong

2

1 reference

22 August 2017

R Cardoso

3

1 reference

22 August 2017

X Zhang

4

1 reference

22 August 2017

D Chin

5

1 reference

22 August 2017

R Hawkins

6

1 reference

22 August 2017

T Dinh

7

1 reference

22 August 2017

M Zhou

8

1 reference

22 August 2017

B Strake

9

1 reference

22 August 2017

P-H Feng

10

1 reference

22 August 2017

M Rocca

11

1 reference

22 August 2017

C Dos Santos

12

1 reference

22 August 2017

X Shan

13

1 reference

22 August 2017

G Danet-Desnoyers

14

1 reference

22 August 2017

F Shi

15

1 reference

22 August 2017

E Kaiser

16

1 reference

22 August 2017

H J Millar

17

1 reference

22 August 2017

S Fenton

18

1 reference

22 August 2017

R Swanson

19

1 reference

22 August 2017

J A Nemeth

20

1 reference

22 August 2017

R M Attar

21

1 reference

22 August 2017

24 February 2017

1 reference

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

2

1 reference

22 August 2017

e536

1 reference

Creative Commons Attribution 4.0 International

22 August 2017

start time

1 February 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/bcj.2017.7

0 references

cites work

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Sensitizing protective tumor microenvironments to antibody-mediated therapy

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Cancer stem cells in bladder cancer: a revisited and evolving concept

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Macrophages as mediators of tumor immunosurveillance

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Integrin-associated protein (CD47) and its ligands

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Role of CD47 as a marker of self on red blood cells

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16)

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

CD47: a potential immunotherapy target for eliminating cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Crosstalk between human IgG isotypes and murine effector cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5386341

Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBCJ.2017.7

inferred from DOI database lookup

7 January 2021

based on heuristic

A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28234345

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BCJ.2017.7

1 reference

22 August 2017

1 reference

22 August 2017

1 reference